about us

Who we are

We are a research and development-driven diagnostic company focused on the development of precision medicine-based diagnostic solutions primarily for oncology but also for hereditary rare diseases and infectious diseases.

One of our primary goals is to enable patients around the world access to more accurate diagnostics and to ensure physicians have the diagnostic tools and data they need to make better therapy recommendations to patients.

As a people and tech-led company, innovation is at the heart of what we do. Much of our focus is dedicated to developing strong partnerships to deliver unique solutions that can improve survival and enhance the quality of life for those battling cancer.

Our History

Established in 2018, AID Genomics is engaged in developing molecular diagnostics for personalized therapeutic approaches in oncology, genetics, and virology. Founding members include Kelvin Wu (our Chairman), Snir Zano (our CEO), and Dr. Izhak Haviv (our Chief Scientific Officer). Also in 2018, AID Genomics acquired Rosetta microRNA patents, for the development of microRNA-based tests to detect, diagnose and provide treatments for various malignancies.

In 2020, AID Genomics was contracted by the Israeli Government to revamp six laboratories and validate the RT-PCR lab protocols and provide COVID-19 PCR testing. In November 2020, AID Genomics built a highly automated laboratory in Jerusalem capable of running 70,000 COVID-19 PCR tests per day.

Currently, the company is expanding its operations, services, and products in Israel and internationally, with a particular focus on the comprehensive sequencing of tissue and liquid biopsies.

Board of Directors

Our Leaders

View Profile
Executive Chairman and Co-Founder
Kelvin Wu

Kelvin Wu has served on our board of directors as our Executive Chairman since 2018. With over 12 years experience as an investment banker, Mr. Wu has led a team in sponsoring and underwriting 25+ IPOs, including some of the most over-subscribed and iconic deals in the Asian financial market history.

read more
View Profile
Chief Executive Officer and Co-Founder
Snir Zano

Snir co-founded AID Genomics with Kelvin and has served as CEO and director since 2018. Prior to that, he was the CEO and Founder of Zano's World, a global homeland security service provider in the field of IoT and cybersecurity.

read more
View Profile
PhD, Chief Scientific Officer
Izhak Haviv

Dr. Izhak Haviv serves as Chief Scientific Officer of AID Genomics. Dr. Haviv is also an honorary associate at the University of Melbourne and a visiting scientist at Peter MacCallum Cancer Centre.

read more
View Profile
PhD – Executive VP, Genomics
Shimon Gross

Shimon Gross is the Executive Vice President of Genomics at AID Genomics. Dr. Gross is an accomplished biomedical sales, marketing and business development professional.

read more
View Profile
Chief Financial Office
Itai Cohen

Itai Cohen serves as Chief Financial Officer at AID Genomics. Mr. Cohen has over 10 years’ experience holding key positions in the Israeli financial markets, including acting as senior manager and C-Level positions in global firms.

read more
View Profile
Chief Marketing Officer
Dor Sultan

Dor Sultan serves as CMO at AID Genomics. Over the past 10 years Mr. Sultan has held several senior management positions, having extensive experience in business strategy, media, marketing and public relations.

read more
View Profile
Ph.D, VP Clinical Affairs
Asaf Gertler

Dr. Gertler serves as our Senior VP of Clinical Affairs. Prior to joining us, Dr. Gertler served as a clinical laboratory director of the pathology department at Hadassah Medical Center both at the Ein Karem and the Mount Scopus sites of Hadassah.

read more
View Profile
Chief Operations Officer
Yannay Ramot

Yannay serves as Chief Operations Officer at AID Genomics and has over 10 years of experience in the Israeli health market.

read more

Follow Us on Social Networks!

want to ask something?

contact us